News
Introduction of five new board nominees with extensive biotechnology backgrounds enhances the company's leadership and strategic focus on oncology and autoimmune diseases. The nominees include ...
Nature Biotechnology has no external editorial board. Instead, all editorial decisions are made by a dedicated team of professional editors with relevant research and editorial backgrounds.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results